Dream Team Leader
Lewis C. Cantley, Ph.D.
Director, Cancer Center
Beth Israel Deaconess Medical Center
Dream Team Co-Leader
Gordon B. Mills, M.D., Ph.D.
Chairman, Department of Systems Biology
Department of Molecular Therapeutics
University of Texas M.D. Anderson Cancer Center
Dream Team Co-Leader
Charles L. Sawyers, M.D.
Chair, Human Oncology and Pathogenesis Program
Memorial Sloan-Kettering Cancer Center
Dream Team Principal
Carlos L. Arteaga, M.D.
Professor of Medicine and Cancer Biology
Vanderbilt University Medical Center
Dream Team Principal
José Baselga Torres, M.D.
Director, Division of Medical Oncology
Vall D’Hebron Institut of Oncology
Hospital Universitari Vall d’Hebron
Dream Team Principal
Ramon E. Parsons, M.D., Ph.D.
Professor
Institute for Cancer Genetics
Columbia University Medical Center
Dream Team Principal
Thomas M. Roberts, Ph.D.
Professor of Pathology, Harvard Medical School
Department of Cancer Biology
Dana-Farber Cancer Institute
Dream Team Advocate
Piru Cantarell, J.D.
Patient Advocate
Director General
Fundación Privada de Estudios Oncológicos
Dream Team Advocate
Ruth G. Fax
Patient Advocate
Dream Team Advocate
Elizabeth S. Frank, M.Ed.
Patient Advocate
Dream Team Advocate
Judity Hirshfield-Bartek, M.S.N
Patient Advocate
Dream Team Advocate
Patricia Lee, M.L.S.
Assistant Director
Eskind Biomedical Library
Dream Team Advocate
Don Listwin
Founder
Canary Foundation
Dream Team Advocate
Jane Perlmutter, Ph.D.
Founder
Gemini Group
Dream Team Advocate
Janet G. Price
Vice President of Research
Manhasset Women's Coalition Against Breast Cancer
Dream Team Advocate
Sara W. Weiss,
Patient Advocate
Investigator
Carol A. Aghajanian, M.D.
Chief Gynecologic Medical Oncology Service
Memorial Sloan-Kettering Cancer Center
Investigator
Donald A. Berry, Ph.D.
Chair, Department of Biostatistics
University of Texas M.D. Anderson Cancer Center
Investigator
Russell R. Broaddus, M.D., Ph.D.
Associate Professor of Pathology
University of Texas M.D. Anderson Cancer Center
Investigator
Robert L. Coleman, M.D.
Professor, Department of Gynecologic Oncology
University of Texas M.D. Anderson Cancer Center
Investigator
J. Dirk Iglehart, M.D.
Director, Breast Cancer Program, Harvard Cancer Center
Dana-Farber Cancer Institute
Investigator
David M. Livingston, M.D.
Emil Frei Professor of Genetics and Medicine, Harvard Medical School
Dana-Farber Cancer Institute
Investigator
Karen H. Lu, M.D.
Professor of Gynecologic Oncology
University of Texas M.D. Anderson Cancer Center
Investigator
Ursula A. Matulonis, M.D.
Director, Medical Gynecologic Oncology
Dana-Farber Cancer Institute
Investigator
Funda Meric-Bernstam, M.D.
Professor, Department of Surgical Oncology
University of Texas M.D. Anderson Cancer Center
Investigator
Andrea P. Myers, M.D., Ph.D.
Postdoctoral and Clinical Fellow
Beth Israel Deaconess Medical Center
Investigator
Pier Paolo Pandolfi, M.D., Ph.D.
Associate Director
Beth Israel Deaconess Cancer Center
Investigator
Andrea L. Richardson, M.D., Ph.D.
Assistant Professor of Pathology
Brigham & Women's Hospital
Investigator
Neal Rosen, M.D., Ph.D.
Enid A. Haupt Chair in Medical Oncology
Memorial Sloan-Kettering Cancer Center
Investigator
Chris Sander, Ph.D.
Chair, Computational Biology Center, Tri-Institutional Professor
Investigator
Robert Soslow, M.D.
Surgical Pathologist
Memorial Sloan-Kettering Cancer Center
Investigator
Cheryl Lyn Walker, Ph.D.
Ruth and Walter Sterling Professor of Carcinogenesis
UT M.D. Anderson Cancer Center
Investigator
Eric P. Winer, M.D.
Director, Breast Oncology Center
Chief, Division of Women’s Cancers
Dana-Farber Cancer Institute
